ALHAMBRA, Calif., Nov. 7, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ('ApolloMed,' and together with its subsidiaries and affiliated entities, the 'Company') (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that it and its affiliated professional entity have entered into a definitive agreement to acquire assets relating to Community Family Care Medical Group IPA, Inc.

加利福尼亚州阿尔哈姆布拉，2023年11月7日/PRNewswire/--阿波罗医疗控股公司（“ApolloMed”，及其子公司和附属实体，“公司”）（纳斯达克：AMEH），领先以医生为中心，技术支持的医疗保健公司专注于使供应商能够成功提供基于价值的医疗服务，今天宣布其及其附属专业实体已签订明确协议，以收购与社区家庭护理医疗集团IPA，Inc相关的资产。

('CFC'), including the CFC independent physician association ('IPA'), the CFC Health Plan ('HP') and CFC's management services organization ('MSO') entities..

（'CFC'），包括CFC独立医师协会（'IPA'），CFC健康计划（'HP'）和CFC的管理服务组织（'MSO'）实体。。

CFC's scaled provider group, with more than 350 primary care physicians and 500 specialists on platform, manages the healthcare of over 200,000 members in the Los Angeles, California area. The group serves patients across Medicare, Medicaid, and Commercial payers. CFC, which became an ApolloMed Care Enablement client in 2020, has a Restricted Knox Keene ('RKK') license for Medicaid members, and will seamlessly integrate as an ApolloMed Care Partner as it continues to utilize our Care Enablement platform..

CFC规模庞大的提供者小组拥有350多名初级保健医生和500名平台专家，负责管理加利福尼亚州洛杉矶地区200000多名成员的医疗保健。该小组为医疗保险，医疗补助和商业支付者提供服务。CFC于2020年成为ApolloMed护理支持客户，拥有Medicaid成员的受限Knox Keene（'RKK'）许可证，并将继续利用我们的护理支持平台无缝整合为ApolloMed护理合作伙伴。。

Brandon Sim, Co-CEO of ApolloMed, stated, 'We're incredibly excited to announce our acquisition of CFC, a scaled, unique network of mission-driven providers with a long track record of strong performance, especially in the Medicaid market in Los Angeles. We believe that pairing CFC's impressive track record and clinical capabilities with ApolloMed's scaled value-based care platform will result in even better outcomes for those we serve.

ApolloMed的联合首席执行官Brandon Sim表示，“我们非常高兴地宣布收购CFC，这是一个规模庞大，独特的任务驱动供应商网络，具有悠久的业绩记录，特别是在洛杉矶的医疗补助市场。我们相信，将CFC令人印象深刻的记录和临床能力与ApolloMed规模化的基于价值的护理平台相结合，将为我们所服务的人带来更好的结果。

We also anticipate that CFC's demonstrated ability to take full risk successfully in Medicaid with its RKK license will allow us to increase our ability to manage a person's total health across our entire Medicaid business. Importantly, this acquisition of an existing client shows the value and synergy of leveraging both our Care Enablement and Care Partners business segments, transitioning from a vendor-client relationship into one in which we are responsible for the total cost of care of their scaled membership base in a de-risked and accretive manner.

我们还预计，CFC凭借其RKK许可证在Medicaid中成功承担全部风险的能力将使我们能够提高在整个Medicaid业务中管理个人整体健康状况的能力。重要的是，这种对现有客户的收购显示了利用我们的护理支持和护理合作伙伴业务部门的价值和协同作用，从供应商-客户关系过渡到我们负责其规模化护理总成本的关系。会员基础以去风险和增长的方式。

We believe that our partnership with CFC and its providers demonstrates our deep commitment to delivering accessible, high-quality, and high-value healthcare to local communities across Los Angeles.'.

我们相信，我们与CFC及其供应商的合作关系表明了我们对为洛杉矶各地的当地社区提供可访问，高质量和高价值的医疗服务的坚定承诺。

Dr. Accie Mitchell, CEO of CFC, commented, 'We are pleased to strengthen our existing relationship with ApolloMed through this transaction, which is a natural progression towards the continued growth and success of CFC. Leveraging ApolloMed's Care Enablement solution has empowered our physicians to deliver better care and enabled the company to deliver a multi-year, growing track record of profitability while managing Medicaid populations under value-based care contracts.

CFC首席执行官Accie Mitchell博士评论说：“我们很高兴通过这项交易加强我们与ApolloMed的现有关系，这是CFC持续增长和成功的自然进展。利用ApolloMed的护理支持解决方案，我们的医生能够提供更好的护理，并使公司能够在基于价值的护理合同下管理医疗补助人群的同时，提供多年，不断增长的盈利记录。

We are incredibly excited for the next chapter of CFC's growth and success in serving those who most need it across Los Angeles and beyond.'.

对于CFC在洛杉矶及其他地区最需要它的人的成长和成功的下一章，我们感到非常兴奋。

For 2023, CFC as a whole is expected to generate approximately $190 million in revenue. CFC's adjusted EBITDA for the full year is expected to be approximately $25 million, reflecting a margin of approximately 13%.

到2023年，整个CFC预计将产生约1.9亿美元的收入。CFC全年调整后的EBITDA预计约为2500万美元，差额约为13%。

Additional details regarding ApolloMed's acquisition of CFC can be found on the Company's Investor Relations website.

有关ApolloMed收购CFC的其他详细信息，请访问公司的投资者关系网站。

Transaction SummaryUnder the terms of the agreement, subject to satisfaction of customary conditions, the purchase price of $202 million is made of $152 million of cash on hand, subject to customary adjustments, $20 million of equity in ApolloMed stock, and up to $30 million in performance-based milestone payments..

交易摘要根据协议条款，在满足习惯条件的情况下，2.02亿美元的购买价格由手头1.52亿美元现金组成，经习惯调整，ApolloMed股票的2000万美元股权，以及高达3000美元基于绩效的里程碑付款。。

ApolloMed's acquisition of the CFC IPA is expected to close in Q1 2024. The acquisition of the CFC HP and the MSO entities are expected to close by the end of Q1 2024, subject to regulatory approval.

ApolloMed收购CFC IPA预计将于2024年第一季度结束。根据监管部门的批准，预计CFC HP和MSO实体的收购将在2024季度末结束。

AdvisorsSheppard, Mullin, Richter & Hampton LLP is serving as legal counsel for CFC. Russ August & Kabat LLP and Nossaman LLP are serving as legal counsel for ApolloMed.

AdvisorsSheppard，Mullin，Richter和Hampton LLP是CFC的法律顾问。Russ August＆Kabat LLP和Nossaman LLP担任ApolloMed的法律顾问。

About Apollo Medical Holdings, Inc.ApolloMed is a leading physician-centric, technology-powered, risk-bearing healthcare management company. Leveraging its proprietary end-to-end technology solutions, ApolloMed operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high quality care to patients in a cost-effective manner..

关于Apollo Medical Holdings，Inc.ApolloMed是一家领先的以医生为中心，以技术为动力，承担风险的医疗保健管理公司。ApolloMed利用其专有的端到端技术解决方案，运营综合医疗保健服务平台，使提供者能够成功参与基于价值的护理安排，从而使他们能够以具有成本效益的方式为患者提供高质量的护理。。

Headquartered in Alhambra, California, ApolloMed's subsidiaries and affiliates include management services organizations (MSOs), affiliated independent practice associations (IPAs), and entities participating in the Centers for Medicare & Medicaid Services Innovation Center (CMMI) innovation models.

ApolloMed总部设在加利福尼亚州阿尔哈姆布拉，其子公司和附属机构包括管理服务组织（MSO），附属独立执业协会（IPA）以及参与医疗保险和医疗补助服务创新中心（CMMI）创新模式中心的实体。

For more information, please visit www.apollomed.net..

欲了解更多信息，请访问www.apollomed.net。。

Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, such as statements about the Company's operational focus and strategic growth plans.

前瞻性声明本新闻稿包含1995年“私人证券诉讼改革法”，1933年“证券法”第27A条（经修订）和1934年“证券交易所法”第21E条（经修订）的前瞻性声明，如关于公司运营重点和战略发展计划的陈述。

Forward-looking statements reflect current views with respect to future events and financial performance and therefore cannot be guaranteed. Such statements are based on the current expectations and certain assumptions of the Company's management, and some or all of such expectations and assumptions may not materialize or may vary significantly from actual results.

前瞻性陈述反映了当前对未来事件和财务绩效的看法，因此无法保证。此类陈述基于当前对公司管理层的期望和某些假设，部分或全部此类期望和假设可能未实现或可能与实际结果有很大差异。

Actual results may also vary materially from forward-looking statements due to risks, uncertainties and other factors, known and unknown, including the risk factors described from time to time in the Company's reports to the Securities and Exchange Commission ('SEC'), including without limitation the risk factors discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC and any subsequent quarterly reports on Form 10-Q..

由于风险，不确定性和其他已知和未知因素，实际结果也可能与前瞻性陈述有很大差异，包括本公司向证券交易委员会（'SEC'）报告中不时描述的风险因素，包括但不限于本公司12月31日止年度10-K表格年度报告中讨论的风险因素，2022年，提交SEC和随后关于表格10-Q的任何季度报告。。

FOR MORE INFORMATION, PLEASE CONTACT:Investor RelationsAsher Dewhurst[email protected]

欲了解更多信息，请联系：投资者关系Sasher Dewhurst[电子邮件保护]

SOURCE Apollo Medical Holdings, Inc.

来源Apollo Medical Holdings，Inc。